AGC Biologics

There's still time to connect in NYC. If you are at the events this week hosted by DCAT (Drug, Chemical & Associated Technologies Association), contact Ben Clauberg, Christoph Winterhalter, and Alberto Santagostino!

Gain insights into the critical aspects of shear forces and oxygen transfer that influence cell health and process efficiency during cell culture scale-up.    Join Tyler Younger, an Upstream MSAT Engineer at AGC Biologics, as he discusses how to optimize parameters such as impellor speed, gas flow rates, and oxygen supply to minimize cell damage while ensuring adequate oxygen delivery for robust cell growth.     Find the link to the on-demand webinar, Shear & Oxygen Mass Transfer Assessment for Cell Culture Scale-Up into 20K L Bioreactor, in the comments below.    #biotech #CellCulture #pharma #LifeScience #biologics #biopharma #YourfriendlyCDMOexpert 

We are excited to be at the Advanced Therapies Congress in London at booth #53!    Be sure to attend the panel discussion on Autologous vs Allogeneic Approaches at 11:00am. Our own Giuliana Vallanti, VP, Development & Global R&D Cell and Gene, will be presenting as part of this insightful presentation.    And, don’t miss the 2:00pm presentation on How a single site became the manufacturer of more than 30% of ex-vivo gene therapy products approved in US/EU, from AGC Biologics’ Luca Alberici, Executive Vice President of Global Cell and Gene Technologies Business & General Manager, Milan.    Stop by our booth or reserve a time to meet with our team members at the event to discuss your next project.    Luca Alberici, Executive VP of Global Cell and Gene Technologies Business & General Manager  Manuel BALBUENA, Director, Business Development  Monika Pema, Process Validation Senior Manager  Silvia P., Associate Proposal Manager  Valentina Boldrin, Project Manager    https://lnkd.in/gnvxsRSX    #AdvancedTherapies #CellandGene #biotech #LifeScience #pharma #YourfriendlyCDMOexpert

BIO-Europe Spring® has officially begun!      Request a meeting with our team or stop by Booth #90 to discuss your protein-based biologics or advanced therapies development and manufacturing needs.     We have several team members in attendance ready to discuss our extensive portfolio of services that include mammalian and microbial bioprocessing, mRNA, cell therapy, viral vector, and plasmid DNA manufacturing.    Reserve a time to meet with Jörg Ohl, Senior Director, Business Development, Samuel Neill, Director, Business Development, or Alexander Ehm, Director, Business Development:  https://lnkd.in/gQbZk4PG    #BIOEuropeSpring #biotech #pharma #LifeScience #biologics #biopharma #YourfriendlyCDMOexpert 

We’re excited to be at DCAT® Week!    Meet with us and learn how we can support and accelerate your product development, from pre-clinical to commercial manufacturing, with our extensive services for the production of protein-based biologics and advanced therapies:   - Mammalian production  - Microbial production  - Viral vectors   - Cell therapy  - Plasmid DNA  - Messenger RNA Request a meeting with our leaders attending the event: Alberto Santagostino, Chief Executive Officer, Christoph Winterhalter, Chief Business Officer, and Ben Clauberg, Vice President of Business Development-Europe.    Let’s discuss partnering on your next project:  https://lnkd.in/gAjdSufJ    #DCATWeek #pharmaceuticals #biotechnology #biologics #advancedtherapies #cellandgene #YourfriendlyCDMOexpert  

Meet Alyssa Floyd (she/her), Manufacturing Training Specialist, who has been with AGC Biologics for just over three years. In her role, Alyssa equips new manufacturing operators with the right knowledge and tools to perform their tasks effectively and compliantly. She works closely with subject matter experts to create impactful learning materials and ensures training programs are executed successfully. Alyssa’s dedication helps maintain the high standards of quality in our operations and makes sure our teams are set up for success. Her passion for helping others grow and her commitment to learning and development is at the core of her work. Outside of work, Alyssa enjoys spending time with her family. Whether hiking, camping, or hosting social events, she loves being outdoors. Alyssa also has a creative side, enjoying activities like painting, photography, and arts & crafts.

AGC Biologics is attending the 24th Congress of The Japanese Society for Regenerative Medicine, March 20-22 at the PACIFICO Yokohama North in Japan! Find us at booth B099    Meet with one of our team members to explore our flexible, end-to-end BravoAAV™ and ProntoLVV™ viral vector production platforms and cell therapy production and manufacturing services that include:  - Proprietary plasmids  - In-house analytical panels  - Master cell banks  - Pre-qualified processes  - Fill and finish services    Request a meeting at the event with one of our Business Development team members:   Ayako Kashima, Director  Kengo Suyama, Director  Naoko Suzuki, Proposal Manager  Eunjin Seul (Lucy), Manager    We look forward to hearing about your project:   https://lnkd.in/grzgTTwN     #biotech #pharmaceuticals #biopharma #pharma #LifeScience #Biotechnology #CellandGene   #YourfriendlyCDMOexpert 

Looking for accelerated and scalable GMP manufacturing of your biologic? Discover our cost-effective AGCellerate™ mAb program enabling rapid delivery of IND material, and the expanded single-use manufacturing footprint at our site in Copenhagen.     In our latest video, Watson Neto, PhD, Director of Process Transfer/MSAT at AGC Biologics Copenhagen, provides a closer look at this innovative program and the flexible technologies and services used at this site (and globally!) for high-quality, large-scale biologics manufacturing.    Link in comments to the full video.    ##biotech #pharmaceuticals #pharma #LifeScience #Biotechnology #biologics #Biopharmaceuticals #biopharma   #YourfriendlyCDMOexpert

AGC Biologics is in London for NextGen Biomed!    Set up a meeting with our team at the event to learn about our extensive development, scale-up, and manufacturing services for protein-based biologics. Our capabilities include:  - Mammalian bioprocessing  - Microbial bioprocessing  - mRNA manufacturing    Request a meeting with Eva Balslev Jørgensen, Senior Director, Business Development, and Samuel Neill, Director, Business Development, to explore ways we can help you advance your biotherapeutic.    https://lnkd.in/gMhVjM6X    #NextGenBiomed2025 #Immunotherapy #Pharma #biopharma #Biotech #Biologics #Vaccines   #YourfriendlyCDMOexpert 

Attention cell and gene therapy professionals! Be sure to join AGC Biologics for the Advanced Therapies Congress, Europe’s largest commercial cell & gene therapy conference, March 18-19, at ExCel London!     Our team will be taking part in two presentations you won’t want to miss on Tuesday, March 18th:    From 11:00am-12:00pm, join Giuliana Vallanti, VP, Development & Global R&D Cell and Gene, as she presents as part of a panel on Autologous vs Allogeneic Approaches.    Then at 2:00pm, Luca Alberici, Executive Vice President of Global Cell and Gene Technologies Business & General Manager, Milan, will be presenting: How a single site became the manufacturer of more than 30% of ex-vivo gene therapy products approved in US/EU.    We would love to connect with you to discuss why AGC Biologics is the right partner - from development to scalable manufacturing to commercialization - for advancing your cell and gene therapies.    Request a meeting with Luca, Giuliana, or our other team members at the event:  Manuel BALBUENA, Director, Business Development  Monika Pema, Process Validation Senior Manager  Silvia P., Associate Proposal Manager  Valentina Boldrin, Project Manager    We look forward to connecting with you! Reserve a time to meet today:  https://lnkd.in/gnvxsRSX    #AdvancedTherapies #CellandGene #biotech #pharmaceuticals #LifeScience #Biotechnology  #pharma  #YourfriendlyCDMOexpert